Physician profile
Scott W Barton
NPI 1588659593
$2,018.90
in general payments reported to CMS, 2019-2025
18 companies · $511 in 2025
The $511 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $116 · 2021: $74.14 · 2022: $519 · 2023: $328 · 2024: $311 · 2025: $511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,149.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $369.39 | 2022-2025 | Cequa |
| Alcon Vision LLC | $360.76 | 2020-2025 | Hydrus Microstent, Clareon Panoptix Pro, Tryptyr |
| Bausch & Lomb Americas INC. | $186.27 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Novartis Pharmaceuticals Corporation | $179.11 | 2019-2023 | |
| Aerie Pharmaceuticals, INC. | $129.86 | 2019-2021 | |
| Allergan, INC. | $123.66 | 2019-2022 | |
| Abbvie INC. | $116.04 | 2022-2023 | Vuity, Lumigan, Alphagan P |
| Tarsus Pharmaceuticals, INC. | $104.70 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $84.66 | 2022-2023 | Tyrvaya |
| Amgen INC. | $76.04 | 2025 | Tepezza |
| Horizon Therapeutics Plc | $63.59 | 2022-2023 | Tepezza |
| Dompe US, INC. | $45.47 | 2024-2025 | Oxervate |
| Thea Pharma INC. | $40.58 | 2023-2025 | Iyuzeh |
| Biotissue Holdings INC. | $39.81 | 2024 | |
| Novo Nordisk INC | $38.81 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lombart Brothers, INC. | $30.65 | 2022 | |
| Kala Pharmaceuticals, INC. | $17.75 | 2021 | |
| Eyevance Pharmaceuticals LLC | $11.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Barton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.